A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
about
Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-riskA comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an exampleSystematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin.The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.Guidelines for prevention of NSAID-related ulcer complications.Evaluation of inconsistency in networks of interventionsIndirect comparisons: a review of reporting and methodological qualityEvaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns.Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in ratsProton pump inhibitors: potential cost reductions by applying prescribing guidelines.Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.The Impact of Excluding Trials from Network Meta-Analyses - An Empirical StudyProton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study.Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations.Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.Limiting paracetamol pack size: has it worked in the UK?Prevalence of upper gastrointestinal bleeding risk factors among the general population and osteoarthritis patients.Risk factors associated with NSAID-induced upper gastrointestinal bleeding resulting in hospital admissions: A cross-sectional, retrospective, case series analysis in valencia, spain.Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors.Gastrointestinal effects of the addition of ascorbic acid to aspirin.Therapeutic management of recurrent peptic ulcer disease.Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori.Choosing and using non-steroidal anti-inflammatory drugs in haemophilia.The effects of excluding treatments from network meta-analyses: surveyDosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study.Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agents.Prescription audit of NSAIDs and gastroprotective strategy in elderly in primary care.Cost effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER).
P2860
Q26864640-047C3D3F-A8FF-4756-9B8B-8352DABA55EFQ28472098-F589FD6B-5C2F-4CC2-B362-466302B5D7B5Q30248439-6FEFC359-FAAF-47C3-B5F1-B19E9272D5ABQ30415171-3D309E67-C7EE-4D12-94C2-3AF127941E06Q33412100-2F72B670-4ECC-43DF-96AF-EB3DAF5470EAQ33620679-A0395B48-6614-4D76-B269-27575F3EBFC4Q33750311-FD4E0161-1419-4E38-A03A-72076867EAD2Q33870087-F6EF6261-374C-44D5-9653-9783DFBB37B1Q34387174-479C8E15-E350-4A02-ADC9-1D9EB646F29AQ34445624-6FDC36B1-9236-4473-99A6-5EDAB541F162Q34481174-25A5735C-400D-4518-AAA3-B727AF1A6B24Q36001198-37125FBA-04A1-4008-B901-C961607E19BCQ36195392-4A32A98E-E593-4037-923E-69A7FA6B0751Q36214975-B47543CE-76E0-45CB-8582-90CC2F25B68DQ36246550-CAB2A26B-9F3C-4A24-B78B-9E0616AB3EB9Q36332697-4CD5A227-F5F4-4F8D-80F8-27B567AB1BABQ37129605-101D5957-F515-4E72-BDA3-8D958DD1EEC1Q37272199-6FC3C9F5-B2FF-452D-8D94-7763D55D77E8Q37358250-8C7F7A8E-E42C-46B7-B8BB-0F8678819059Q37385351-0B142E75-6E1B-4D0C-AAC9-D2A4790ED414Q37536003-51827288-5125-4D35-94DF-207C8C97D9EBQ37538954-5EE5EB9C-CAE2-4A79-A8E3-738F87110157Q37663470-7CC38355-9547-4A72-95A5-DEDE90D53BAEQ37808208-EED61E5C-67E2-4752-845B-4A5122E77CBCQ37965938-5DD68E88-5BC5-45BA-BB03-48E1465EE6C6Q38032319-976F66CA-F2FD-41FA-A95C-7EB4728EE46BQ38194659-7C7F57A1-453B-46D5-884B-1CEC639E0E4DQ38625670-7249238D-3996-44CE-B002-9ECBDFBC2733Q41834701-E9AFAFB5-2C34-4586-B68A-4849788EF236Q44452482-9C0E5CE1-7ED5-4EBD-8E20-C79CF4B7F74FQ45093563-F99E9A0D-F393-41E4-8F7E-1BAAEF9D2A00Q48666627-7F79F9AA-9773-4B1F-B17A-1BF801FE5E41Q53290843-C3A31060-8F11-436E-A398-31912CF8AD40
P2860
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A comparison of the cost-effec ...... eview with economic modelling.
@ast
A comparison of the cost-effec ...... eview with economic modelling.
@en
type
label
A comparison of the cost-effec ...... eview with economic modelling.
@ast
A comparison of the cost-effec ...... eview with economic modelling.
@en
prefLabel
A comparison of the cost-effec ...... eview with economic modelling.
@ast
A comparison of the cost-effec ...... eview with economic modelling.
@en
P2093
P356
P1476
A comparison of the cost-effec ...... eview with economic modelling.
@en
P2093
R A Elliott
P304
iii-iv, xi-xiii, 1-183
P356
10.3310/HTA10380
P577
2006-10-01T00:00:00Z